Japan Clinical Cancer Research Organization

The fields where it stands highest, over all time, ranked among every institution above the floor in each field.

Each strip is that field’s whole ranked pool, with the notch where Japan Clinical Cancer Research Organization sits in it, in the colour of the band that rank falls in. The track under the rate is the rate itself: it carries no world mark, because the world rate differs by field (from about 6% to 21% in this record).

Where its research is concentrated relative to its size: Medicine takes 4.2× the share of its output that it takes of world research.

1. MedicineField · 29.3 works4.2×
2. Health SciencesDomain · 29.9 works3.6×

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Medicine 4.2×
• Biochemistry, Genetics and Molecular Biology 1.5×
• Dentistry 0.9×
• Immunology and Microbiology 0.8×
• Economics, Econometrics and Finance 0.7×
• Mathematics 0.6×
• Psychology 0.6×
• Decision Sciences 0.5×
• Nursing 0.5×
• Health Professions 0.4×
• Physics and Astronomy 0.3×
• Neuroscience 0.3×
• Computer Science 0.1×
• Engineering 0.1×
• Agricultural and Biological Sciences 0.0×
• Materials Science 0.0×
• Social Sciences 0.0×

Ranked on the composite score, Taro Shibata, Ryunosuke Machida and Kōichi Deguchi lead among researchers whose main affiliation is Japan Clinical Cancer Research Organization.

1. 1 🇯🇵 Taro Shibata Japan · #101,329 worldwide 183 citations · 38 works
2. 2 🇯🇵 Ryunosuke Machida Japan · #746,017 worldwide 33 citations · 25 works
3. 3 🇯🇵 Kōichi Deguchi Japan · #1,231,066 worldwide 25 citations · 74 works
4. 4 🇯🇵 Keita Sasaki Japan · #1,414,310 worldwide 12 citations · 43 works
5. 5 🇯🇵 S Fukayama Japan · #1,496,597 worldwide 4 citations · 35 works
6. 6 🇯🇵 R Ishihara Japan · #1,514,874 worldwide 3 citations · 34 works
7. 7 🇯🇵 N Yokota Japan · #1,517,280 worldwide 5 citations · 30 works
8. 8 🇯🇵 M Koguchi Japan · #1,527,113 worldwide 2 citations · 32 works
9. 9 🇯🇵 Y Nakane Japan · #1,567,506 worldwide 2 citations · 25 works

By fractional works in 2022–2025, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Endoscopic Resection, Targeted Therapy, Prognostic Factors, Epidemiology, Survival Analysis and Adjuvant Therapy.

By volume in 2022–2025: Gastric Cancer Management and Outcomes, Lung Cancer Treatments and Mutations, Esophageal Cancer Research and Treatment and Cancer Genomics and Diagnostics.

1. 1 Gastric Cancer Management and Outcomes Pulmonary and Respiratory Medicine 2 works
2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 1 works
3. 3 Esophageal Cancer Research and Treatment Surgery 1 works
4. 4 Cancer Genomics and Diagnostics Cancer Research 1 works
5. 5 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 1 works
6. 6 Colorectal Cancer Treatments and Studies Oncology 1 works
7. 7 Cancer Immunotherapy and Biomarkers Oncology 1 works
8. 8 Frailty in Older Adults Geriatrics and Gerontology 1 works
9. 9 HER2/EGFR in Cancer Research Oncology 1 works
10. 10 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 1 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 5% lower than in 2013–2017.

• The University of Tokyo
• Tokyo Institute of Technology
• Keio University
• Waseda University
• Tokyo University of Science
• Nihon University
• Hitachi (Japan)
• NTT (Japan)